1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legislation

PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises

 
• By Ryan Nelson

The Personal Care Products Council outlines a list of “principles” that it believes should guide legislation to update cosmetics regulations. Many of its priorities could be seen as aligning more closely with reintroduced House legislation than the less industry-friendly Personal Care Products Safety Act in the previous Senate, signaling a possible change in strategic direction at PCPC under the new Administration.

The Personal Care Products Council continues to support legislative efforts to update cosmetics regulations in the US, committed to working “with all stakeholders” in the new Congress, according to a Jan. 18 statement.

It remains to be seen whether PCPC will adopt a new legislative strategy under the Trump Administration in line with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

California Microbeads Legislation Moves Toward Passage As DTSC Proposes Restrictions

 
• By Lauren Nardella

Multiple microbeads measures in California could impact how manufacturers selling products in the state approach reformulation.

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By Lauren Nardella

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.

Sunscreen Regulation Reforms Still Could Hitch Ride On Senate OMUFA Reauthorization Bill

As stakeholders and lawmakers pin their hopes on OMUFA reauthorization as a vehicle for enacting sunscreen regulatory changes, Senate version of the bill could be the ticket after a sunscreen-specific amendment withdrawn in the House.

Unanimous Support Across House Energy And Commerce To Reauthorize FDA’s OMUFA Program

 
• By Malcolm Spicer

Committee voted 51-0 to approve five-year authorization of FDA program user fee program needed to support regulatory pathway for large majority of nonprescription drugs available in the US with amendment to expand stakeholder engagement with FDA.

More from Policy & Regulation

US FDA Independence Questioned At CDC Oversight Hearing

 
• By Michael McCaughan

A Senate committee is investigating leadership changes at the US Centers for Disease Control and Prevention. While the primary focus is vaccine policy, the first hearing suggested the probe could raise questions about FDA independence.

New Reviews Support Safety Of UV Filters Avobenzone, Ensulizole; May Help Fill Data Gaps

 
• By Lauren Nardella

New studies examining avobenzone and ensulizole safety add to the body of evidence for the UV filters’ use in sunscreens.

Cosmetics AE Protection Program Taps Medical Experts To Address Potential Overreporting Of SAEs

 
• By Eileen Francis

Registrar Corp. and non-profit health care provider Denver Health announce the launch of Adverse Events Protection Program, a fully integrated solution to help cosmetics companies track and investigate adverse events.